Back to search

Article

Identification of a 10-Gene Signature Model to Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.

2021-01-20

Abstract excerpt

<title>Abstract</title> <p>BackgroundPatients with human epidermal growth factor receptor 2 (HER2) positive breast cancer represent a poor prognosis, which are recommended to be treated with neoadjuvant therapy (NAT). Tumor immune microenvironment, especially tumor infiltrating cells (TILs), are proved to predict the efficacy of NAT. However, validated immune-related multi-gene signatures for HER2-positive BC are...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8b273110-ba78-592e-b74c-ddc6aa8c5780
DOI
10.21203/rs.3.rs-148991/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of a 10-Gene Signature Model to Predict Efficacy of Neoadjuvant Therapy in Patients With HER2&nbsp;Positive Breast Cancer.DOI 10.21203/rs.3.rs-148991/v1
Identification of A 10-Gene Signature To Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.Semantic proximity
Identification of immune-related biomarkers for predicting neoadjuvant chemotherapy sensitivity in HER2 negative breast cancer via bioinformatics analysisSemantic proximity
Immune Effective Score As A Predictor Of Response To Neoadjuvant Trastuzumab Therapy And A Prognostic Indicator For HER2-positive Breast CancerSemantic proximity
Identification and Validation of Immune-Related Gene Prognostic Signature for breast cancerSemantic proximity
Immune-related Gene Data-based Molecular Subtyping Related to the Prognosis for Breast Cancer PatientsSemantic proximity
Landscape of Immune Cell Infiltration and Inflammatory Response-related Gene Signature in Breast Cancer: an Experimental Validation StudySemantic proximity
Combination of Immune-Related Network and Subtype-Specific Analysis Define a Three- Gene Panel for Predicting Prognosis of Triple-Negative Breast CancerSemantic proximity
Identification of an Independent Immune-Genes&nbsp;Prognostic Index for Breast CancerSemantic proximity
Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancerSemantic proximity
Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast CancerSemantic proximity
Identification of an immune cell infiltration-related gene signature for prognosis prediction in triple-negative breast cancer.Semantic proximity
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Estrogen Receptor (ER) or Progesterone Receptor (PR) Positive and Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerSemantic proximity
Select a neighboring publication to make it the new centre.